Transparency concerns at drug pricing patient sessions
Listen now
Description
CMS is holding public listening sessions on Medicare price negotiations for the first 10 drugs selected, but reporting uncovered concerns patient advocates and the pharma industry have over transparency and potential conflicts of interest from some speakers. Host Ben Leonard talks with POLITICO health care reporter David Lim about the ties some speakers have to the industry or advocacy groups.
More Episodes
Artificial intelligence is changing the way doctors practice, but also how the health care business runs. Host Chelsea Cirruzzo talks with POLITICO health care reporter Daniel Payne about the ways AI is already used across the medical landscape and how regulators are responding.
Published 12/22/23
Published 12/22/23
As federal officials scramble to regulate artificial intelligence in health care, HHS has already become one of the top federal agencies using the technology. Host Kelly Hooper talks with POLITICO health reporter Chelsea Cirruzzo about some of the 80 implemented or planned uses of AI by HHS...
Published 12/21/23